Sanofi said on
Tuesday that the International Chamber of Commerce ruled in its
favour in an arbitration case over claims by Boehringer
Ingelheim that Sanofi should be liable for ongoing. | June 20, 2023
In a research note published by Richard Vosser, JP Morgan advises its customers to buy the stock. The target price remains unchanged at EUR 105. | June 20, 2023
FDA Advisory Committee unanimously recommends nirsevimab as first immunization against RSV disease for all infants Nirsevimab would be the first immunization specifically designed to protect all. | June 8, 2023
Sanofi shares stand out with an interesting technical chart pattern displaying horizontal consolidation. One would assume that the current accumulation phase will cede eventually to an acceleration to. | June 7, 2023
In a research note, JP Morgan analyst Richard Vosser has maintained his recommendation on the stock with a Buy rating. The target price continues to be set at EUR 105. | May 31, 2023